Browsing by Author Horwood, Keith

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2012Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST studyBoyer, Michael; Pavlakis, Nick; Abell, Fiona; de Souza, Paul; Horwood, Keith; Johnston, Michael; Millward, Michael; Rischin, Danny; Stein, Brian; Central Clinical School: Medicine; Northern Clinical School: MedicineEfficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study, Asia Pacific Journal of Clinical Oncology, vol.8, 3, 2012,pp 248-254
2014Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: A prospective analysisButow, Phyllis; deFazio, Anna; Price, Melanie; Beesley, Vanessa; Clavarino, Alexandra; Green, Adele C.; Horwood, Keith; O'Rourke, P; Webb, Penelope M.; Wockner, Leesa; Wyld, David; Psychology; Western Clinical School: Westmead Institute for Medical Res; PsychologyQuality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: A prospective analysis, Gynecologic Oncology, vol.132, 1, 2014,pp 130-136
2011Second-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study.van Zandwijk, Nico; Heigener, David; Horwood, Keith; Mali, Pekka; Reck, Martin; Wu, Yi-long; Concord Clinical School: ANZAC Research InstituteSecond-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study., Lung cancer, vol.74, 2, 2011,pp 274-279